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The incidence of placental attachment disorders continues to
increase with rising caesarean section rates. Antenatal diagnosis
helps in the planning of location, timing and staffing of delivery.
In at-risk women grey-scale ultrasound is quite sensitive, although
colour ultrasound is the most predictive. Magnetic resonance
imaging can add information in some limited instances. Patients
who have had a previous caesarean section could benefit from
early (before 10 weeks) visualisation of the implantation site.
Current data refer only to placentas implanted in the lower
anterior uterine segment, usually over a caesarean section scar.
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Introduction
Risk factors for placental attachment disorders (PAD) have
been clearly documented—placenta praevia, previous cae-
sarean section and age are the most common.1,2 More
infrequent risk factors are Asherman syndrome3 and endo-
metrial ablation.4–6 An increase has also been seen in in
vitro fertilisation pregnancies.7 Placenta accreta, increta and
percreta (abbreviated as placental attachment disorders or
PAD in the following discussion) account for 33–50% of
all emergency peripartum hysterectomies.8–10 Clearly this is
a major healthcare problem.
The exact process by which PAD is initiated is still
unknown but is probably more complicated than just
abnormal decidualisation of a scarred area or lack of
decidua in the lower uterine segment near the cervix.
The consequences are often caesarean hysterectomy and
the end of fertility, as well as increased rates of blood
loss and transfusion, injury to surrounding organs, and
increased rates of intensive care admission when com-
pared with women who undergo caesarean section for
placenta praevia alone.11 Forewarning and preparation,
including a multidisciplinary approach, do help to reduce
morbidity,12–14 but even with careful preparation morbid-
ity can be considerable.11,15–17 Delivery at an institution
with experience, operative resources, and access to large
amounts of blood and blood replacement products is
ideal because significant amounts of blood can be lost
and it is not possible to predict which women will lose
the most.16
The following discussion reviews the two major diagnos-
tic modalities, ultrasound and magnetic resonance imaging
(MRI), used at the present time to attempt a prenatal
diagnosis. There has been a change in the past several
years in the evidence for various techniques used to make
a diagnosis.
Methods
A PUbMed search was made using the terms ‘placenta
accreta’, ‘diagnosis of placenta accreta’, ‘imaging of pla-
centa accreta’, ‘magnetic resonance in placenta accreta’,
‘placenta percreta’, ‘colour Doppler ultrasound and pla-
centa accreta’, ‘magnetic resonance imaging in placenta ac-
creta’,’early diagnosis placenta accreta’, and ‘caesarean scar
pregnancy’. In the evaluation of imaging signs only original
papers published in English or translated into English were
used. Pathological examination of the uterus was the pre-
ferred proof of an accreta because myometrial fibrils can
normally be found on removed placentas and clinical
descriptions by multiple clinicians regarding causes of
bleeding and difficulty removing a placenta can be subjec-
tive. An emphasis was placed on recent papers because
MRI resolution and colour Doppler continue to improve.
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Ultrasound
First trimester
We know that placenta accreta and percreta can occur in a
first-trimester pregnancy from reports in which a dilatation
and curettage was performed with subsequent massive
bleeding.18–21 When the uterus was examined the placenta
was found to be invasive or adherent with lack of decidua
between the myometrium and placenta. It is reasonable to
assume that abnormal placentation was present from the
time of implantation. Although a few cases have been
reported in women with no previous uterine surgery, the
most frequent risk factor was previous caesarean section. In
a small series of women who had proven PAD, four of
whom had reached near term, retrospective review of all
available first-trimester scans showed the gestational sac
implanted low and anteriorly rather than in its normal fun-
dal position (Figures 1 and 2) in all six women who had
had previous caesarean sections. The anterior myometrium
was thin but visible over the scar. In the one case in which
the sac was fundal in location there had been no previous
lower uterine scar.22 If the diagnosis had been made in the
first trimester a recommendation would have been made to
terminate the pregnancy because rupture of the uterus with
ensuing maternal shock in the second and early third tri-
mesters is a risk. This study was repeated by Ballas, but in a
wider gestational age range of 8.5–14 weeks.23 In the two
early cases (8 weeks) the sacs were located in the lower uter-
ine segment. The average gestational age in the other eight
women was 13 weeks and, although it was stated that these
gestational sacs were implanted low, it would be difficult to
determine this in most cases. However, in eight of the ten
women, including those at 8 weeks of gestation, echolucent
areas were seen in the placentas, confirming a previous
report of early lacunae,24 and nine had an irregular pla-
centa–myometrium interface.
These low-lying sacs should be differentiated from the
occasional sac found in the lower uterine segment associ-
ated with impending demise and subsequent passage, or
even the occasional normal pregnancy, though this is quite
rare (Figure 1B). Impending demise can be distinguished
from both a normal but low implanted pregnancy and a
pregnancy implanted on a scar by lack of surrounding
blood flow and by movement within the cavity when pres-
sure is exerted on the anterior uterus.
The overall incidence of these early accreta pregnancies
is not known, but presumably if all women with previ-
ous caesarean sections who are later identified as having
PAD were scanned before 10 weeks of gestation (when
A
B
Figure 1. (A) Early pregnancy. Sagittal view. Normal implantation of a
gestational sac in the fundus (arrowhead). Cervix near long arrow. (B)
Low implanted sac in a pregnancy which went to term. Cervix and
internal os near arrow. Note the thick anterior myometrium and the
continuous white line representing the bladder–uterine wall interface.
Figure 2. Low implanted pregnancy in placenta accreta. Sagittal view.
The sac is implanted low and anteriorly on a caesarean section scar
(long arrow). The anterior myometrium is very thin. Fluid outlines the
confines of the endometrial cavity.
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the sac does not occupy the entire uterine cavity) the
gestational sac would be implanted in the anterior lower
uterine segment.
Occasionally these cases of first-trimester PAD are
termed ‘cervicoisthmic’ pregnancies, although that term
implies growth of the placenta into the cervix as well as the
myometrium. Although this term does not apply to every
pregnancy attached to a caesarean scar, certainly in some
there is extension into the cervix. Their course is similar
however—they can proceed to term at which time
attempted separation of the placenta results in massive
haemorrhage.25
The literature and terminology are confusing because
those pregnancies implanted low on a caesarean section
scar are usually termed ‘scar pregnancies’, although that
term strictly applies only to pregnancies that are actually
within the scar surrounded by myometrium and therefore
not within the endometrial cavity.26,27 In a retrospective
review of hysterosalpingograms in 150 women with previ-
ous caesarean sections, 60% had defects at the site of the
incision of which 65% were focal outpouchings and 35%
were linear defects.28 True scar pregnancies lying com-
pletely within the myometrium would be a consequence
of entry of the fertilised ovum into one of these linear
sinus tracks within the scar. They can be responsible for
a mass within the myometrium but outside the endome-
trial cavity and are obviously missed on dilatation and
curettage. Continuing positive pregnancy tests and a sup-
rapubic mass suggest the diagnosis.29 They have never
been described as proceeding to the third trimester,
unlike pregnancies implanted upon the scar (rather than
within it). Confusion has also ensued because some
authors have used the term ‘scar pregnancy’ for pregnan-
cies implanted in the niche left from a previous caesar-
ean section, but not surrounded by myometrium on all
sides and therefore are not true ‘scar pregnancies’.
Because they lie within the divot left by a scar they can
also be missed during early curettage, but presumably as
they enlarge they grow out into the endometrial cavity.
Recent review papers of ‘scar pregnancies’ actually appear
to include a mixture of niche implantations and true scar
pregnancies because some were managed by injection and
then dilatation and curettage.30,31 For the latter to be
successful, the pregnancy could not have been sur-
rounded on all sides by myometrium. In either case the
clinical management would be the same as reviewed
recently.28,30,31
Second and third trimesters
Results can be divided into several parts: the performance
of particular ultrasound signs, the overall accuracy of ultra-
sound in the diagnosis, the performance of MRI alone, and
lastly the comparison of ultrasound to MRI. Ultrasound
sensitivity depends on which imaging criteria are used.
Clear space. In many women with normal placentation a
hypoechogenic space can be observed between the placenta
and myometrium (Figure 3). However, McGahan et al.
observed the clear space to be missing in a large percentage
of normal pregnancies with anterior placentas but found it
to be almost always present in women with a posterior pla-
centa.32 Finberg and Williams first noted that the absence
of the retroplacental clear space was the one finding that
accounted for almost all false positives in the diagnosis of
PAD,33 a finding that has been confirmed by others.34,35
Wong et al. found absence of the clear space in 37 (65%)
women without placenta accreta and in 100% of those
women with it.36 Hence, it is sensitive but not specific. The
primary use of the clear space appears to be that its pres-
ence effectively excludes placenta accreta because it has a
Figure 3. Sagittal view. Left, clear space (arrows) and right, absence of clear space in women with a normal pregnancy. Bl bladder.
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high negative predictive value (NPV).35,36 These findings
are listed in Table 1.
Bladder line interruption. The interface between the uterus
and bladder is represented on grey scale sonography as a
continuous white line (Figure 3). Its loss can be relatively
obvious (Figure 4) or more subtle, seen best on transvagin-
al ultrasound with a partially full bladder. In their large (41
women) pathology-proven series of women with previous
caesarean sections and anterior placentas, Cali et al. con-
firmed Finberg and Williams findings that this is the sign
with the highest positive predictive value (PPV) for
PAD.33,35 The interruption of this line is a result of
increased vascularity in this space, as they showed using
colour Doppler; it does not signify invasion of the bladder
because interruption can be seen in placenta accreta. They
showed that when this hypervascularity extends the entire
width of the bladder–uterine interface placenta percreta is
probable (see Colour Doppler section).
The cause of the low sensitivity reported in the papers by
both Comstock et al. and Wong et al. may be that not all
women had transvaginal ultrasound with the quite specific
conditions used by Cali et al.35 In that large study the
authors first determined that 300 ml in the bladder resulted
in the best visualisation of the uterine–bladder interface and
then instilled this amount into each woman’s bladder. Per-
formance of bladder line interruption is summarised in
Table 2.
Lacunae. The PPV of lacunae shows more variation from
author to author than other signs of PAD. When observed
by colour Doppler and spectral ultrasound, lacunae have
high-velocity and low-resistance flow and are irregular in
cross-section on grey-scale sonography35 (Figure 5). They
are located deep in the placenta, not under the fetal surface
of the placenta (Figure 6), and are irregularly shaped, not
round as are placental lakes. They have been reported as
Table 1. Utility of the clear space in diagnosis of PAD
Author Sensitivity
(%)
Specificity
(%)
PPV NPV
Comstock et al.34 73 14
Wong et al.36 100 35 20 100
Cali et al.35 90.2 80.8 57 96.7
A
B
Figure 4. (A) Grey-scale sagittal view. Arrowhead shows loss of the
usual white bladder–uterine serosal line. The large irregular space
(medium arrow) is a lacuna and the mottled appearance near the large
arrow represent very small ones. (B) Colour Doppler of the same area
showing flow within the large lacunae.
Table 2. Utility of interrupted bladder line in the diagnosis of PAD
Study Sensitivity
(%)
Specificity
(%)
PPV NPV
Cali et al.35 70 99 96 92
Comstock et al.34 20 75
Wong et al.36 11 100 100 88
Figure 5. Placenta lacunae as seen with colour Doppler.
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sensitive and specific in some studies and not so in others.
Comstock et al. found them to be 93% sensitive in women
at 20 weeks of gestation and beyond with a 93% PPV.34
The more lacunae the more likely there is placenta percre-
ta.33 Using Finberg’s scale of grade 0 when none were seen,
1+ when one to three small lacunae were present, 2+ when
four to six larger or more irregular ones were seen and
grade 3+ when there were many throughout the placenta,
Yang et al. also found that cases of normal placentation had
grades 0 or 1, in placenta accreta half had grade 0 and half
had grade 1, and in increta or percreta only grades 2 and 3
occurred .37 Grade 1 and above were associated with signifi-
cantly increased rates of transfusion, disseminated intravas-
cular coagulation, intensive care unit admission, and
caesarean hysterectomy. Unfortunately 30% of women,
those without caesarean hysterectomies, had evaluation of
the placenta alone, which has been noted (above) to be
unreliable. Despite the lack of pathology confirmation this
study is included because it was done transvaginally and the
results were divided into grades. The conclusion that can be
drawn is that the more lacunae the more likely there will be
a necessity of caesarean hysterectomy. This was confirmed
by Chou et al. in a study with a high caesarean hysterec-
tomy rate and therefore pathology confirmation.38 Cali
et al. found that six or more lacunae were associated with
placenta percreta in all 17 of their cases.35 Lacunae can
appear as early as 8 weeks.24,25 The utility of lacunae in the
diagnosis of PAD is summarised in Table 3.
Myometrial thickness. Myometrial thickness of less than
1 mm has been investigated by several authors.39,40 Its use
is confounded by the fact that the myometrium of the
lower uterine segment naturally thins as term is
approached, but Wong et al. found a sensitivity of 22%,
specificity of 100%, PPV of 100% and NPV of 89% (nine
women) and Twickler et al. found a sensitivity 100%, spec-
ificity 72%, PPV 72%, and NPV 100% (nine women). Loss
of the myometrial wall higher in the uterus can be omi-
nous (Figure 7).
Ultrasound—colour/colour power/colour power
three-dimensional Doppler
One of the best uses of colour Doppler is to investigate the
presence or absence of flow within echolucent areas of the
placenta: lacunae are very obviously high flow areas. How-
ever, if on grey scale the lacunae are irregularly shaped and
within the substance of the placenta, then colour Doppler
probably does not add information.
There is normally a clear demarcation of placenta from
the uterus, even in the absence of a clear space, with the
placental edge forming a well-defined arc. Wong et al. have
written about ‘tissue interface disruption’ on grey scale in
which this usual smooth interface between the uterus and
placenta is disrupted (Figure 5). On colour Doppler, vessels
can be seen bridging the placenta to myometrium. When
the two findings were combined in a small series of nine
women, sensitivity, specificity, PPV and NPV were 89, 96,
80 and 98%, respectively.
Chou et al. found that high-flow vessels linking the pla-
centa and bladder had a high sensitivity and specificity for
PAD.38 However, they warned that care must be taken to
show that these vessels truly connect the placenta and blad-
der because two false positives were the result of bladder
varices in women who had had previous caesarean sections.
Its use in distinguishing placenta accreta from placenta per-
creta is discussed below.
Interruption of the uterine serosa bladder line is proba-
bly caused by hypervascularity. This appears to be easier to
detect using colour Doppler than grey scale since Cali et al.
noted a 70% sensitivity using grey scale but a 90% sensitiv-
ity using colour Doppler.35
Placenta accreta is not necessarily more benign than pla-
centa increta or percreta17—large amounts of blood can be
lost in either case. However, several authors have attempted
to distinguish accreta from increta in the antenatal period.
Using three-dimensional colour Doppler both Cali et al.
Table 3. Utility of lacunae in the diagnosis of PAD
Study Sensitivity
(%)
Specificity
(%)
PPV NPV
Cali et al.35 73 86 60 90
Comstock et al.34 93 93
Wong et al.36 100 28 21 100
Yang et al.37, Gr. ≥ 1 86.9 78.6 76.9 88
Yang et al.34, Gr. ≥ 2 100 97.2 93.8 100
Gr 1 = grade 1 (one to three lacunae), Gr. 2 = grade 2 (four to six
lacunae).
Figure 6. Dark spaces under the fetal surface of the placenta (arrows)
should not be mistaken for lacunae.
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and Chalubinski et al.41 found that extension of large vessels
over the width of the placenta, from left to right, correlated
with placenta percreta. Using three-dimensional colour
power Doppler Cali et al. demonstrated that the increased
vascularity seen at the uterine bladder interface extended
from side to side (as seen on the coronal view) in all 17
cases of placenta percreta with a sensitivity, specificity, NPV
and PPV of 90, 100, 100 and 97%, respectively (Figure 8).
In the latter, placenta accreta/normal placenta was able to
be separated from placenta increta/percreta with 100% sen-
sitivity, specificity, PPV and NPV using this method.41
Combination of ultrasound (grey scale and colour Doppler)
signs
The accuracy of diagnosis appears to improve using
more than one ultrasound finding. Using three grey-scale
signs (clear space, bladder line interruption, lacunae) and
two three-dimensional colour Doppler signs (tortuous
confluent vessels crossing placenta width and hypervascu-
larity of uterine serosa bladder wall) Cali et al. found
that all 41 women with PAD had two or more signs.
Half of the women with four signs had placenta percreta
and all of the women with five signs had placenta per-
creta. None of the women without PAD had more than
one criteria. Comstock et al. used three grey-scale signs
and found that when using two or more criteria the sen-
sitivity was 80% and the PPV was 86%. However, lacu-
nae by themselves had a higher sensitivity of 93% and a
PPV of 93%.34 Esakoff et al. found that grey scale ultra-
sound had an overall sensitivity of 89%, specificity of
91%, PPV of 68% and NPV of 97.6%. However, no
analysis was published of individual signs.11 This paper
A
B
Figure 7. (A) Placenta percreta into the broad ligament. The uterine
wall (arrowheads) disappears in the area of the arrows. (B) No uterine
wall is seen between the placenta and the veins of the broad ligament.
There are large lacunae within the placenta.
A
B
Figure 8. Three-dimensional power Doppler imaging, coronal view. (A)
Serosa bladder wall interface neovascularisation (arrows) involving part
of the bladder–uterine interface in placenta accreta and (B) involving all
of the interface from side-to-side (arrows) in percreta. (Cali et al., with
permission from Ultrasound Obstet Gynecol).
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also differed from that of Cali et al. by including all
women with placenta praevia whether or not they had
had previous surgery.
Magnetic resonance imaging
There are three areas to be addressed when assessing MRI in
the detection of PAD: the best MRI signs, the sensitivity and
specificity compared to ultrasound, and the determination of
when this more expensive test can contribute additional
information. Unfortunately, the number of different study
designs and the relatively low number of women make MRI
difficult to evaluate. Confounding this is a variation of ultra-
sound criteria used for comparison and, in addition, using
multiple interpreters.42 Almost all studies required a suspi-
cious ultrasound examination before the woman was sent for
MRI, which created an ascertainment bias and alerted the
reader that the woman had an abnormal ultrasound exami-
nation.42–46 Additionally, some papers did not require
pathology proof but relied on varying clinicians’ opinions as
to difficulty of removing the placenta42,46–48 or in most
women relied on examination of the placenta alone for a
histological diagnosis.42,46,48 Others involved more than one
hospital and non-uniform MRI protocols.45
One paper involved the use of gadolinium as a second
MRI test but did not separate the results of the first stage
from the second.46 Gadolinium is known to cross the pla-
centa and to be excreted by the fetal kidney. Since the
effects on fetal growth and fetal kidneys are unknown it
is not routinely used, although it certainly increases the
contrast between the uterus and placenta.46 Many studies
did not provide enough clinical information to judge in
which women MRI would provide better information
than ultrasound.
Lim et al., however, performed MRI on at-risk women
regardless of positive or negative ultrasound findings, had
pathological proof of PAD from caesarean hysterectomies
and included considerable clinical information.49 The MRI
was interpreted by one experienced person. They found
that the volume of dark placental bands (first described by
Lax) was the most predictive finding in true PAD (Fig-
ure 9). These bands were also seen in women without PAD
but in those they were quite small in volume. Whether
these bands represent haemorrhage or infarct or fibrosis is
not clear and the authors warn that it is possible that these
could be found in cases of placental infarction from other
causes such as intrauterine growth restriction. In the one
case that was a false positive on both ultrasound and MRI
the ultrasound diagnosis was made using absence of the
clear space, the most common cause of a false-positive
ultrasound. The MRI finding was a large band in a woman
found to have a large placental infarct but with no PAD.
Not enough data were presented to determine the sensitiv-
ity and specificity and NPV and PPV of ultrasound versus
MRI. Although the authors state that MRI was more sensi-
tive, the difference was one case. Lacunae were found in
the ultrasound examinations of all true positives and no
true negatives. Unfortunately, ultrasound criteria did not
include evaluation of the uterine–bladder wall line or
require transvaginal ultrasound. Two cases had false-nega-
tive ultrasound and MRI—both were accretas with blood
loss of just 1000 ml. In these two cases of false-negative
ultrasound and MRI and in one additional one in which
ultrasound was negative but MRI was positive the placentas
were lateral or posterior, not implanted over the caesarean
section scar. In all three cases blood loss was minimal and
the diagnosis was accreta. Could the lack of findings be
related to their location away from the scar?
Derman et al. confirmed others’ findings that the most
reliable sign is the larger dark band on T2 Haste series.44
They added an additional finding—vessels of 6 mm or
greater (which presumably correspond to lacunae).
A
B
Figure 9. MRI of dark bands. (A) Dark arrows point to dark band
measurements in the cross-sectional view (B) and in the sagittal view to
calculate the volume of the band. (Lim et al., with permission from
AJR).
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Alamo et al. found that the sensitivity and specificity of
MRI depended upon both the type of attachment disorder
and also the experience of the observer.45 In a study of 25
women with possible PAD on ultrasound, 12 were proven
to have either accreta, increta or percreta by pathology
examination of a removed uterus. Experienced readers
detected PAD with 90% sensitivity and a 75% specificity
whereas junior readers were 81% sensitive and 75% specific
(all blinded to outcome). Junior readers were as skilled at
detecting the most distinguishing sign of PAD—dark intra-
placental bands. However, in distinguishing placenta accreta
and increta from placenta percreta, senior readers had a
sensitivity of 92% and specificity of 90% versus 76 and
88%, respectively, for junior readers. Hence, senior readers
were particularly good at detecting infiltration of adjacent
organs by evaluating tenting of the bladder, interruption of
the myometrial line and direct infiltration of pelvic organs.
Of course the number of placentas percreta was small (five),
as in most studies. Overall they found T2 hypointense pla-
cental bands, a focally interrupted myometrial border, infil-
tration of the pelvic organs and tenting of the bladder to be
the best signs. Bulging of the uterus was not helpful because
this can be seen in women with negative results. The sagittal
view was much preferred, as other investigators have men-
tioned, and fast imaging with steady-state precession and
single fast spin t2w sequences were the most useful.
All studies of MRI versus ultrasound are underpowered.
Dwyer et al. calculate that 194 women would need to have
both ultrasound and MRI in a paired study design to have
an 80% power to detect a difference at the P = 0.05 level,
and even more women would be needed in an unpaired
study design.43 In their study no significant difference
between the two modalities could be shown. They did find
them to be complementary—when sonography was inconclu-
sive MRI provided the correct diagnosis in four of five women
and when MRI was inconclusive sonography provided the
correct diagnosis in seven of eight women. They found that
the ability of either to correctly diagnosis PAD was not
affected by history of uterine surgery or placental location.
Discussion
As the number of cases has increased, awareness of the
possibilities and importance of antenatal diagnosis has
resulted in more attempts to identify reliable diagnostic
signs. Colour Doppler ultrasound, and particularly the use
of three-dimensional colour Doppler, has made visualisa-
tion of vessels much easier. MRI has advanced in acquisi-
tion times and thinness of slices. The major papers with
good pathological correlation have been reviewed here.
The strongest of these is the paper by Cali et al.—with 41
pathology-proven cases and use of both colour and
three-dimensional Doppler.
Findings can be seen as early as a gestational sac can be
identified if the sac is implanted in the anterior lower uter-
ine segment. In the second and third trimesters findings
may be seen as early as 18 weeks.34 Possible errors include
using the absence of the clear space alone to make the
diagnosis and confusing lacunae with placental lakes or
subchorionic fluid collections and failing to evaluate the
uterine bladder line with transvaginal ultrasound.
Colour Doppler in the hands of experienced people can
add information and, when available in three dimensions,
can distinguish accreta from percreta in most cases. The util-
ity of this effort though is controversial because placenta ac-
creta, the most benign of the three possibilities, can result in
as much bleeding as a placenta percreta. Both require delivery
at institutions able to transfuse large quantities of blood.
Although new surgical approaches have been proposed, such
as hypogastric artery balloons, these have not been defini-
tively shown to reduce blood loss and may not be available.
Ureteral stents often, but not always, help in avoiding tran-
section of the ureters. Still there may be extensive growth into
the broad ligament, bowel or bladder requiring some addi-
tional surgical skills either from the primary surgeon or con-
sultant that are more likely to be available in a larger hospital.
Although the incidence of placenta accreta is on the
rise, most institutions still see few cases, making the power
of most studies inadequate. To overcome this, some inves-
tigators have gathered cases from several institutions.
Unfortunately, these are almost always retrospective and
not organised so that the same ultrasound signs and inter-
preters are used across locations. In addition, most inter-
preters are not blinded. In many publications reports of
difficulty removing a placenta are used rather than proof
from pathological evaluation of the uterus. Although this
method may identify mild placenta accreta, many observ-
ers are involved and it is hard to interpret difficulty in
removing the placenta or causes of bleeding. In other pub-
lications examination of the placenta is used to make the
diagnosis but it is known that myofibrils on a placenta do
not make a diagnosis of placenta accreta—they can be
found on placentas with uneventful deliveries. Additional
limitations are found in papers comparing ultrasound and
MRI because usually the woman had to have had a suspi-
cious or inconclusive ultrasound examination to be
referred, so introducing ascertainment bias. Often the
ultrasound examination in those studies was from a refer-
ring institution and was not re-evaluated by the group
performing the MRI study. Most limitations were men-
tioned in the results.
The questions remain as to when and what MRI can
contribute. If an ultrasound examination is thought to be
positive there is little to be gained from MRI. However, if
the findings suggest possible percreta or are inconclusive or
negative in an at-risk woman MRI can be useful. Invasion
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of adjacent organs can be seen better on MRI than on
ultrasound. Situations in which MRI may also contribute
additional information include women with placenta prae-
via with a posterior or lateral implantation, a posterior scar
from a myomectomy, a history of difficult placental
removal in the past with a posterior or lateral placenta in
the present pregnancy, or a history of endometrial ablation
Women with placental implantation not over a scar
include women who have had a caesarean section but have
implantation and accreta posteriorly and women who have
never had uterine surgery. There is very little data about
women who have not had uterine surgery because in most
papers this is a requirement for inclusion. Interestingly in the
above paper on reader experience only three of the 12 with
PAD had had a previous caesarean section although 11 or
the 12 had a placenta praevia.45 Hence this may be one of the
few papers that addresses placenta accreta in the absence of
previous uterine surgery. No comments were made as to the
location of the placenta in the women or any differences in
the findings between those who had had previous surgery
and those who had not. We do know that placenta praevia
alone is a risk factor for PAD and in the paper by Lim et al.
there was one woman out of nine without previous surgery.
In that case there were typical findings on both ultrasound
and MRI for PAD. The ultrasound examination showed a
lateral praevia with lacunae and the MRI showed a moder-
ate-size dark band. Chou et al. notes that in all three women
with false-negative colour Doppler results the placentas were
posterior. Levine et al. noted one false-negative ultrasound
diagnosis in a posterior placenta in their series.50 Hence there
is scant information about the ultrasound or MRI findings in
women who have placenta praevia but have had no previous
uterine surgery or in whom the placenta is not implanted
over a caesarean section scar.
Should women who have had a caesarean section be
screened for placenta accreta early in pregnancy? A pro-
spective screening study divided 105 at-risk women from
11 to 14 weeks of gestation into high-risk and low-risk cat-
egories depending on whether or not the placenta was over
the identified uterine scar as seen on transvaginal ultra-
sound.51 Among the six women in the high-risk group just
one had PAD at term. Interestingly, that woman was the
only one who had an anterior low-lying placenta when
scanned again early in the second trimester. No mention
was made about lacunae. Available retrospective studies
suggest that if the woman is at high risk (multiple caesar-
ean sections, previous difficulty removing the placenta,
endometrial ablation) an early scan before 10 weeks, rather
than at 11–14 weeks, could be very useful if it shows a low
implanted sac with a thin anterior uterine wall. In the
interests of the mother’s health and future reproduction,
this pregnancy could then be interrupted because it will
probably lead to placenta accreta, or worse, uterine rupture
from a percreta. Conversely, a normally implanted sac in the
upper half of the uterus would make PAD highly unlikely.
Occasionally a woman will not have any risk factors or
any imaging findings and still have PAD with severe haem-
orrhage, and even death, even at large and well-staffed hos-
pitals, but it is the hope that prenatal imaging will reduce
this previously not uncommon occurrence.
Conclusions
The consequences of an undetected placenta accreta can be
severe, so antenatal detection is ideal. The first and most
important step is to maintain a high index of suspicion:
women should be asked about previous uterine surgery,
endometrial ablation or assisted reproduction both during
initial prenatal visits and at the time of ultrasound imaging.
It is important that facilities without colour Doppler or
MRI facilities should still attempt screening. Fortunately
the most readily available modality, grey-scale ultrasound,
has a good sensitivity and PPV (although colour Doppler is
the most sensitive). In the absence of colour Doppler, or in
addition to it, examination of the bladder–uterine interface
for interruption with a partially filled bladder and transva-
ginal ultrasound appears to be the most useful sign. Placen-
tal lacunae are the next most useful and the absence of the
clear space, although sensitive, is very non-specific and a
source of false positives. MRI has not proved as useful as
initially hoped but may provide additional information in
women who are at risk but do not have anterior placentas
or in whom the ultrasound findings are difficult to inter-
pret. It is important to remember that the ultrasound find-
ings described in the literature have to this point almost
always only described implantation anteriorly in the lower
uterine segment of women with placenta praevia and a pre-
vious caesarean section. No papers have addressed imaging
in cases of accreta elsewhere such as the fundus.
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Commentary ‘All women with prior caesarean section should
have a 6- to 8-week scan to predict placenta accreta’
The systematic review by Comstock et al., published in this issue, gives us confidence that an early ultrasound scan is
sensitive and specific for the detection of placenta accreta. Appraisal of current scientific knowledge about placenta
accreta will lead to the belief that we are in a cul-de-sac with this serious condition. There is an abundance of knowl-
edge on the association of scar pregnancy and abnormal adherence of the placenta (Fylstra Ob Gynecol Survey 2002
57:537–543; Timor-Trisch et al. AJOG 2012;207:44.e1–13), This clinical link remains under-utilised. We think that it
provides a clue to the solution of the problem of placenta accreta and suggests a hypothesis.
Figure 1. The fate of a low pregnancy sac in a scarred uterus.
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In this hypothesis, we propose that all women who have had previous caesarean sections should have a transvaginal
scan examination between 6 and 8 weeks of gestation in any subsequent pregnancy. The purpose of this scan would be
to identify the implantation site of the gestational sac. If the scan showed that the sac was implanted in the fundus, this
should rule out the possibility of a scar pregnancy and the potential of placenta accreta in a woman with a previous
scar. The other possibility is that of a low or isthmic gestational sac. This has a higher chance of adverse events, includ-
ing miscarriage, scar pregnancy and placenta accreta. Women with a low gestational sac would be categorised as higher
risk and require further evaluation and monitoring.
We think it possible to screen based on fundal versus non-fundal or low pregnancy implantation, particularly when
the gestational sac is small. Visualisation of the small, early gestational sac in relation to the uterine fundus could
develop into a simple screening test (see Figure 1). As the gestational sac becomes larger it fills the whole cavity and it
encroaches on the niche of the previous caesarean section scar. Identification of the original implantation site will
therefore become harder.
A screening programme to identify the location of the gestational sac at 6–8 weeks of gestation would be simple and
could provide both women and obstetricians with the valuable knowledge of not having a risk of placenta accreta if
the gestational sac was fundal.
We believe that minimal changes in training would be required. Research will provide women and clinicians with
therapeutic options, including termination of pregnancy if a scar, isthmic or low gestational sac was shown to be firmly
associated with placenta accreta. Research should be funded and encouraged to clarify the poorly understood natural
history of caesarean section scar pregnancies. It is not known what proportion (if not all) of low implantations result
in caesarean section scar pregnancies/placenta accreta. Without this information, one runs a possible risk of suggesting
termination for a pregnancy that may never have developed into accreta. Termination of a pregnancy implanted in the
scar is not without risks. Implementation is possible only after the natural history of placenta accreta is understood
and after trials have assessed the benefits, risks and cost of such a screening programme.
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